EAST-AFNET 4
2020
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial
In 2,789 patients with early AF (≤ 1 yr), early rhythm-control therapy reduced CV death, stroke or hospitalisation for HF or ACS versus usual care.
Result
Efficacy: Composite CV death, stroke, HF/ACS hospHR 0.79
Below 1 favours early rhythm-control therapy, above 1 favours usual care.
Event rates Early rhythm-control therapy 3.9 vs usual care 5.0 per 100 patient-years
- Subtopic
- Rate vs rhythm
- Design
- Open-label, blinded endpoint, median 5.1 yr
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2024 AFACC/AHA 2023 AF
- Source
- Kirchhof P, et al. N Engl J Med. 2020;383(14):1305-1316.doi 10.1056/NEJMoa2019422
Discussion & critique
Reopened the rhythm-vs-rate question, but only for AF diagnosed in the last year. ~ 8 % had ablation by 2 yr; mostly drug-based.